Abstract
Background
Slow transit constipation (STC) is caused by intestinal peristalsis dysfunction and is closely associated with disturbance of the intestinal microecological balance. Bacillus subtilis plays a positive role in the treatment of STC, but its mechanism needs to be further explored.
Aims
The purpose of the present study was to explore the effects and mechanism of B. subtilis on the pathophysiology of STC.
Methods
A STC mouse model was established with compound diphenoxylate, following which B. subtilis was used to treat STC. The effects and possible mechanism of B. subtilis on STC were investigated by assessing intestinal motility, histology of the colon, release of 5-HT in enterochromaffin cells (ECs) and the TGR5/TRPA1 pathway. Moreover, LC-MS targeted metabolomics was used to analyze the regulation of Bacillus subtilis on bile acid metabolisms in STC mice.
Results
Bacillus subtilis significantly increased 24 h defecations, fecal moisture and intestinal transport rate of STC mice, improved pathological damage of the colon and showed protective effects on the intestinal tract. The release of 5-HT from ECs and the bile acid receptor TGR5/TRPA1 pathway were significantly increased in STC mice treated with B. subtilis. In addition, the metabolomics results showed that the bile acid contents of STC mice were significantly decreased, and B. subtilis could increase the bile acid composition and content of STC mice.
Conclusion
Bacillus subtilis regulates intestinal peristalsis of STC by promoting the release of 5-HT from ECs through bile acid metabolism and its receptor TGR5 pathway and plays a positive role in the treatment of STC.
Similar content being viewed by others
Availability of data and materials
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Pannemans J, Van den Houte K, Fischler B, Piessevaux H, Carbone F, Tack J. Prevalence and impact of self-reported painful and non-painful constipation in the general population. Neurogastroenterol Motil 2020;32:e13783.
Sailer M. Slow transit constipation. Zentralbl Chir 2019;144:179–189.
Black CJ, Ford AC. Chronic idiopathic constipation in adults: epidemiology, pathophysiology, diagnosis and clinical management. Med J Aust 2018;209:86–91.
Ceresola ER, Ferrarese R, Preti A, Canducci F. Targeting patients’ microbiota with probiotics and natural fibers in adults and children with constipation. Eur Rev Med Pharmacol Sci 2018;22:7045–7057.
Kimelman H, Shemesh M. Probiotic bifunctionality of Bacillus subtilis-rescuing lactic acid bacteria from desiccation and antagonizing pathogenic staphylococcus aureus. Microorganisms 2019;7:107.
Wu C, Ouyang M, Guo Q et al. Changes in the intestinal microecology induced by bacillus subtilis inhibit the occurrence of ulcerative colitis and associated cancers: a study on the mechanisms. Am J Cancer Res 2019;9:872–886.
Yano JM, Yu K, Donaldson GP et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 2015;161:264–276.
Alemi F, Poole DP, Chiu J et al. The receptor TGR5 mediates the prokinetic actions of intestinal bile acids and is required for normal defecation in mice. Gastroenterology 2013;144:145–154.
Talavera K, Startek JB, Alvarez-Collazo J et al. Mammalian transient receptor potential TRPA1 channels: from structure to disease. Physiol Rev 2020;100:725–803.
Nozawa K, Kawabata-Shoda E, Doihara H et al. TRPA1 regulates gastrointestinal motility through serotonin release from enterochromaffin cells. Proc Natl Acad Sci U S A 2009;106:3408–3413.
Takano Y, Machida T, Obara Y et al. Methotrexate causes a change in intestinal 5-hydroxytryptamine metabolism in rats. Eur J Pharmacol 2014;740:496–503.
Takano Y, Hirano M, Machida T et al. Nitric oxide plays a critical role in methotrexate-induced hyperplasia of enterochromaffin cells containing 5-hydroxytryptamine in rat small intestine. J Pharmacol Sci 2019;141:32–40.
Gershon MD, Tack J. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 2007;132:397–414.
Jani B, Marsicano E. Constipation: evaluation and management. Mo Med 2018;115:236–240.
Deng Z, Fu Z, Yan W et al. The different effects of Chinese Herb Solid Drink and lactulose on gut microbiota in rats with slow transit constipation induced by compound diphenoxylate. Food Res Int 2021;143:110273.
Göthert M, Bönisch H, Malinowska B, Schlicker E. Serotonin discovery and stepwise disclosure of 5-HT receptor complexity over four decades. Part II. Some contributions of Manfred Göthert. Pharmacol Rep 2020;72:271–284.
Israelyan N, Del Colle A, Li Z et al. Effects of serotonin and slow-release 5-hydroxytryptophan on gastrointestinal motility in a mouse model of depression. Gastroenterology 2019;157:507-521.e4.
Stasi C, Bellini M, Bassotti G, Blandizzi C, Milani S. Serotonin receptors and their role in the pathophysiology and therapy of irritable bowel syndrome. Tech Coloproctol 2014;18:613–621.
Watts SW. The love of a lifetime: 5-HT in the cardiovascular system. Am J Physiol Regul Integr Comp Physiol 2009;296:R252–R256.
Park KR, Kim EC, Hong JT, Yun HM. Dysregulation of 5-hydroxytryptamine 6 receptor accelerates maturation of bone-resorbing osteoclasts and induces bone loss. Theranostics 2018;8:3087–3098.
Bunnett NW. Neuro-humoral signalling by bile acids and the TGR5 receptor in the gastrointestinal tract. J Physiol 2014;592:2943–2950.
Guo C, Chen WD, Wang YD. TGR5, not only a metabolic regulator. Front Physiol 2016;7:646.
Lieu T, Jayaweera G, Bunnett NW. GPBA: a GPCR for bile acids and an emerging therapeutic target for disorders of digestion and sensation. Br J Pharmacol 2014;171:1156–1166.
Zhao J, Lin King JV, Paulsen CE, Cheng Y, Julius D. Irritant-evoked activation and calcium modulation of the TRPA1 receptor. Nature 2020;585:141–145.
Doihara H, Nozawa K, Kojima R et al. QGP-1 cells release 5-HT via TRPA1 activation; a model of human enterochromaffin cells. Mol Cell Biochem 2009;331:239–245.
Doihara H, Nozawa K, Kawabata-Shoda E et al. TRPA1 agonists delay gastric emptying in rats through serotonergic pathways. Naunyn Schmiedebergs Arch Pharmacol 2009;380:353–357.
Kojima R, Nozawa K, Doihara H et al. Effects of novel TRPA1 receptor agonist ASP7663 in models of drug-induced constipation and visceral pain. Eur J Pharmacol 2014;723:288–293.
Slattery SA, Niaz O, Aziz Q, Ford AC, Farmer AD. Systematic review with meta-analysis: the prevalence of bile acid malabsorption in the irritable bowel syndrome with diarrhoea. Aliment Pharmacol Ther 2015;42:3–11.
Wald A. Bile acids and bowel function: do they play a role in constipation-associated irritable bowel syndrome? Clin Gastroenterol Hepatol 2018;16:486–487.
Chadwick VS, Gaginella TS, Carlson GL, Debongnie JC, Phillips SF, Hofmann AF. Effect of molecular structure on bile acid-induced alterations in absorptive function, permeability, and morphology in the perfused rabbit colon. J Lab Clin Med 1979;94:661–674.
Camilleri M, Vijayvargiya P. The role of bile acids in chronic diarrhea. Am J Gastroenterol 2020;115:1596–1603.
Barkun AN, Love J, Gould M, Pluta H, Steinhart H. Bile acid malabsorption in chronic diarrhea: pathophysiology and treatment. Can J Gastroenterol 2013;27:653–659.
Camilleri M. Bile acid diarrhea: prevalence, pathogenesis, and therapy. Gut Liver 2015;9:332–339.
Quigley EM, Spiller RC. Constipation and the microbiome: lumen versus mucosa! Gastroenterology 2016;150:300–303.
Kawamata Y, Fujii R, Hosoya M et al. A G protein-coupled receptor responsive to bile acids. J Biol Chem 2003;278:9435–9440.
Wahlström A, Sayin SI, Marschall HU, Bäckhed F. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab 2016;24:41–50.
Russell DW. The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem 2003;72:137–174.
Watanabe M, Houten SM, Mataki C et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 2006;439:484–489.
Funding
This work was supported by Basic Research and Frontier Exploration Project of Yuzhong District, Chongqing, China (No. 20190140).
Author information
Authors and Affiliations
Contributions
XZ and ZHC conceived and designed the research. ZHC performed most of the experiments. JYF and SH performed parts of the experiments. YH, SYM, WJF and QY analyzed the data. ZHC and XZ wrote the manuscript. All data were generated in house. All authors agree to be held accountable for all aspects of the research and confirm that the data are accurate.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Chen, Z., Feng, J., Hu, S. et al. Bacillus Subtilis Promotes the Release of 5-HT to Regulate Intestinal Peristalsis in STC Mice via Bile Acid and Its Receptor TGR5 Pathway. Dig Dis Sci 67, 4410–4421 (2022). https://doi.org/10.1007/s10620-021-07308-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-021-07308-4